|
?:authorAffiliation
|
-
[\'Office of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: jhewitt@nih.gov.\', \'In Vivo Pharmacology, The Jackson Laboratory, Bar Harbor, ME 04609, USA.\', \'Office of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Office of the Commander, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.\', \'Sanofi Research and Development, Sanofi, Cambridge, MA 02139, USA.\', \'Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.\', \'Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. Electronic address: haigwoon@ohsu.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}